FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

732936001: Tablet (unit of presentation)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2017. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498396015 Tablet (unit of presentation) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3498397012 Tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
799361000241114 comprimé fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
3357851001000118 Tablette de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tablet (unit of presentation) Is a Unit of presentation (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Amlodipine (as amlodipine besilate) 5 mg and valsartan 80 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely acalabrutinib 100 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely acalabrutinib 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 325 mg and caffeine 15 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Aspirin 325 mg and caffeine 15 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Aspirin 325 mg and caffeine 15 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely alprazolam 3 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely phenobarbital 50 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely phenobarbital 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbamazepine 600 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbamazepine 150 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely carbamazepine 300 milligram/1 each prolonged-release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely bromazepam 6 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely bromazepam 6 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely oxazepam 25 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely oxazepam 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 850 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Canagliflozin 150 mg and metformin hydrochloride 850 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely canagliflozin 150 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely canagliflozin 150 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canagliflozin 150 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely canagliflozin 50 milligram and metformin hydrochloride 1 gram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Estradiol 1 mg and norethisterone acetate 1 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and atorvastatin (as atorvastatin calcium) 40 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and atorvastatin (as atorvastatin calcium) 40 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and atorvastatin (as atorvastatin calcium) 40 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 10 milligram and atorvastatin (as atorvastatin calcium) 40 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Dydrogesterone 2.5 mg and estradiol 500 microgram oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Dydrogesterone 2.5 mg and estradiol 500 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dydrogesterone 2.5 mg and estradiol 500 microgram oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely dydrogesterone 10 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dydrogesterone 10 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dydrogesterone 10 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely dydrogesterone 5 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely dydrogesterone 5 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely dydrogesterone 5 milligram and estradiol 1 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Dydrogesterone 10 mg and estradiol 2 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Dydrogesterone 10 mg and estradiol 2 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Dydrogesterone 10 mg and estradiol 2 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Amlodipine (as amlodipine besilate) 10 mg and atorvastatin (as atorvastatin calcium) 20 mg and perindopril arginine 10 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Bictegravir (as bictegravir sodium) 50 mg and emtricitabine 200 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir alafenamide (as tenofovir alafenamide fumarate) 25 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Emtricitabine 200 mg and rilpivirine (as rilpivirine hydrochloride) 25 mg and tenofovir disoproxil (as tenofovir disoproxil fumarate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil maleate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely efavirenz 600 milligram and emtricitabine 200 milligram and tenofovir disoproxil (as tenofovir disoproxil phosphate) 245 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Efavirenz 600 mg and emtricitabine 200 mg and tenofovir disoproxil (as tenofovir disoproxil succinate) 245 mg oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 10 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 10 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 10 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 10 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 5 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 2
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and atorvastatin (as atorvastatin calcium) 20 milligram and perindopril arginine 10 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 3
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely sodium valproate 150 milligram/1 each gastro-resistant oral tablet (clinical drug) Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1
Sodium valproate 300 mg gastro-resistant oral tablet Has unit of presentation True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept)
Sodium valproate 300 mg gastro-resistant oral tablet Has presentation strength denominator unit (attribute) True Tablet (unit of presentation) Inferred relationship Existential restriction modifier (core metadata concept) 1

Start Previous Page 85 of 87 Next End

This concept is not in any reference sets

Back to Start